Comprehensive HPV Screening Important in Male Urology, Fertility Clinics
By Elana Gotkine HealthDay Reporter
.jpg?width=1200)
FRIDAY, Aug. 23, 2024 -- Comprehensive human papillomavirus (HPV) screening, including genotyping, is important in urology and fertility clinics, according to a study published online Aug. 23 in Frontiers in Cellular and Infection Microbiology.
Carolina Olivera, Ph.D., from the FOCIS Center of Excellence Centro de Inmunología Clínica de Córdoba in Argentina, and colleagues examined the influence of high-risk HPV (HR-HPV) and low-risk HPV (LR-HPV) urogenital infection on male fertility in a study involving 205 male patients attending a urology clinic. Semen samples were analyzed for HPV; the quality of semen was assessed following World Health Organization guidelines.
The researchers detected HPV in 19 percent of semen samples. HR-HPV infections were more prevalent; the most frequent genotype was HPV-16. No significant alterations in routine sperm quality parameters were seen in association with HR-HPV or LR-HPV. However, significantly higher levels of sperm necrosis were seen in HR-HPV-positive individuals compared with LR-HPV-positive or control individuals, and they had increased proportions of reactive oxygen species-positive spermatozoa. Neither patients infected with HR-HPV nor LR-HPV had significant semen inflammation detected; compared with controls, unexpectedly reduced serum leukocytes and inflammatory cytokines (interleukin 6 and interleukin 1β) were seen in HR-HPV-positive patients.
"A more thorough evaluation, including genotyping, is essential for males seeking care at urology and fertility clinics, since the specific HPV genotype may influence the course of the infection and its consequences on reproductive health," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Fertility Rate Decreased 1 Percent From 2023 to 2024
THURSDAY, July 24, 2025 -- From 2023 to 2024, there was a 1 percent increase in the number of births and a 1 percent decrease in the general fertility rate, according to a July...
Depressive Symptoms Common for Women With Premature Ovarian Insufficiency
TUESDAY, July 22, 2025 -- The prevalence of depressive symptoms is high among women with premature ovarian insufficiency (POI), according to a study published online July 16...
Updated Guidance Improves Staging of HPV-Positive Oropharyngeal Cancer
MONDAY, July 21, 2025 -- Version nine of the American Joint Committee on Cancer (AJCC) and Union for International Cancer Control staging system (AJCC9V) human papillomavirus...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.